Laura R. Lander, MSW, LICSW
PO Box 9137
930 Chestnut Ridge Road
Morgantown, WV 26505
Nguyen L, Lander LR, O'Grady KE, Marshalek PJ, Schmidt A, Kelly AK, Jones HE. Treating women with opioid use disorder during pregnancy in Appalachia: Initial neonatal outcomes following buprenorphine + naloxone exposure. Am J Addict. 2018 Mar;27(2):92-96. doi: 10.1111/ajad.12687. Epub 2018 Feb 23. https://www.ncbi.nlm.nih.gov/pubmed/29473258
Zheng, W., Nickasch, M., Lander, L., Wen, S., Xiao, M., Marshalek, P., Dix, E, Sullivan, C. (2017). Treatment Outcome Comparison between Telepsychiatry and Face-to-face Buprenorphine Medication-Assisted Treatment (MAT) for Opioid Use Disorder: A 2-Year Retrospective Data Analysis. Journal of Addiction Medicine, 11(2), 138–144. http://doi.org/10.1097/ADM.0000000000000287
Laura Lander, Kathleen Chiasson-Downs, Michael Andrew, Gerald Rader, Sheena Dohar, and Kimberly Waibogha, Yoga as an Adjunctive Intervention to Medication-Assisted Treatment with Buprenorphine+Naloxone, Journal of Addiction Research & Therapy 2017, 8:6, DOI: 10.4172/2155-6105.1000354
Keith J. Zullig ,Laura R. Lander, Samantha Sloan, Michael R. Brumage, Gerry R. Hobbs, Laurel Faulkenberry., Mindfulness-Based Relapse Prevention with Individuals Receiving Medication-Assisted Outpatient Treatment for Opioid Use Disorder, Mindfulness, April 2018, Volume 9, Issue 2, pp 423–429, https://doi.org/10.1007/s12671-017-0784-0
Zheng, Wanhong, Nickasch, Michael, Lander, Laura, Wen, Sijin, Xiao, Minchan, Marshalek, Patrick, Dix, Ebony, Sullivan, Carl. Treatment Outcome Comparison between Telepsychiatry and Face-to-face Buprenorphine Medication-assisted Treatment for Opioid Use Disorder: A 2-Year Retrospective Data Analysis. Journal of Addiction Medicine. 11(2):138-144, March/April 2017. DOI: 10.1097/ADM.0000000000000287
Zullig, K, Lander, L, Sloan, S, Brummage, M, Hobbs, G, Faulkenberry, L. Mindfulness-Based Relapse Prevention with Individuals Receiving Medication-Assisted Outpatient Treatment for Opioid Use Disorder, Mindfulness. 8/2017. DOI 10.1007/s12671-017-0784-0
Lander, L & Marshalek, P. Opioid Use Disorder Among Pregnant Women: effective substance abuse treatment considerations. Paradigm. 21(4) 2017, 20-22.
Stabler ME, Long DL, Chertok IR, Giacobbi PR Jr, Pilkerton C, Lander LR. Neonatal Abstinence Syndrome in West Virginia Substate Regions, 2007-2013. The Journal of Rural Health, 2016 Feb, doi 10.1111/jrh. 12174
Zheng WH, Wakim RJ, Geary RC, Lander LR, Wen SJ, Xiao MC and Sullivan CR. Self-reported Sleep Improvement in Buprenorphine MAT (Medication Assisted Treatment) Population. Austin Journal of Drug Abuse and Addiction - Vol.3, Issue 1 -2016; 3 (1): 1009.
Stabler M, Gurka K, Lander L. Association between Childhood Residential Mobility and Non-Medical Use of Prescription Drugs among American Youth, submitted to Maternal and Child Health Journal, Aug, 2014.
Lander L, Gurka K, Marshalek P, Riffon M, Sullivan R. Treatment of Pregnant Women With Opioid Use Disorders on Buprenorphine in Pregnancy-Only vs. Mixed-Gender Groups, submitted to SW Research, (2015) 39 (4): 235-244.
Byrne M & Lander L. (2014) Chapter 4: Socio-environmental Aspects of substance Use Disorders. In A. Douaihy & D. Daley (Eds), Substance Use Disorders (Pittsburgh Pocket Psychiatry Series). New York: Oxford University Press.
Lander L, Marshalek P, Yitayew M, Ford D, Sullivan C, Gurka K. (2013) Rural Healthcare Disparities: Challenges and Solutions for the Pregnant Opioid-dependent Population. West Virginia Medical Journal Accepted for publication July 2013.
Shockey, A, Wilson CS, Lander L, Baretto, G, Szklarz, G, VanVoorhis, G, Minardi, J. (2013). The effect of rural upbringing and education on the intent of health professional students to work in rural settings. International Journal of Medical Education Volume 4, 18-25.
White RJ, Zullig KJ, Lander L, Shockley C, Pack RP, Sullivan C. (2012). The West Virginia Prescription Drug Abuse Quitline: Challenges and Lessons Learned from Running a Remote Quitline, Health Promotion Practice Volume 13(1), 81-89.